Evidence map›Paper›PMID 15735665›Full record

ArticleOncogene2005

topors, a p53 and topoisomerase I-binding RING finger protein, is a coactivator of p53 in growth suppression induced by DNA damage.

Ling Lin, Toshinori Ozaki, Yuki Takada, Hajime Kageyama, Yoko Nakamura, Akira Hata, Jian-Hua Zhang, William F Simonds, Akira Nakagawara, Haruhiko Koseki

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Regulating tumor suppressor genes: post-translational modifications.Signal transduction and targeted therapy · 2020
    Review
  14. Review
  15. Regulation of the p53 Family Proteins by the Ubiquitin Proteasomal Pathway.International journal of molecular sciences · 2019
    Review
  16. Review
  17. Article
  18. Review
  19. Role of E3 ubiquitin ligases in lung cancer.World journal of clinical oncology · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Ling LinDepartment of Molecular Embryology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.
Toshinori Ozaki
Yuki Takada
Hajime Kageyama
Yoko Nakamura
Akira Hata
Jian-Hua Zhang
William F Simonds
Akira Nakagawara
Haruhiko Koseki
Chiba Cancer Center · JPChiba University · JPNational Institute of Diabetes and Digestive and Kidney Diseases · US

Funding

Clinical Investigation of FIHP, Parathyroid Cancer & the HPT-JT SyndromeZIADK043012 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI SIMONDS, WILLIAM F · 2009 to 2025
$4.3M
Investigation of Familial Isolated Hyperparathyroidism aZ01DK043012 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI SIMONDS, WILLIAM F · 2002 to 2008
$534k
6 · The paper itself

Abstract

The RING family zinc-finger protein topors (topoisomerase I-binding protein) binds not only topoisomerase I, but also p53 and the AAV-2 Rep78/68 proteins. topors maps to human chromosome 9p21, which contains candidate tumor suppressor genes implicated in small cell lung cancers. In this study, we isolated the murine counterpart of topors and investigated its impact on p53 function. The deduced amino-acid sequence of mouse topors exhibits extensive similarity to human topors. Overexpressed myc-tagged topors associates with and stabilizes p53, and enhances the p53-dependent transcriptional activities of p21(Waf1), MDM2 and Bax promoters and elevates endogenous p21(Waf1) mRNA levels. Overexpression of topors consequently results in the suppression of cell growth by cell cycle arrest and/or by the induction of apoptosis. Taken together, these studies identify topors as a positive regulator of p53. The expression of topors is induced by exposure to the genotoxic reagents cisplatin and camptothecin, a DNA topoisomerase I inhibitor. We therefore postulate that topors mediates p53-dependent cellular responses induced by DNA damage, suggesting its physiological role as a tumor suppressor.

Indexed as

DNA DamageGene Expression RegulationAmino Acid SequenceAnimalsAntineoplastic AgentsAntineoplastic Agents, PhytogenicApoptosisBone NeoplasmsCamptothecinCarrier ProteinsCell CycleCisplatinDNA-Binding ProteinsDNA Topoisomerases, Type IGenes, Tumor SuppressorHumansAntineoplastic AgentsAntineoplastic Agents, PhytogenicCamptothecinCarrier ProteinsCisplatinDNA-Binding ProteinsDNA Topoisomerases, Type INeoplasm ProteinsNuclear ProteinsTOPORS protein, humanTranscription FactorsTumor Suppressor Protein p53Ubiquitin-Protein Ligases

Identifiers

PMID15735665
OpenAlexW1997769119

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.